BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25494564)

  • 1. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.
    Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD
    J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the long-term impact of public investments in comparative effectiveness research: conceptual framework and lessons learned.
    Rich EC; Esposito D; Kimmey LD; Valenzano CS; Yong PL
    J Comp Eff Res; 2014 Nov; 3(6):657-66. PubMed ID: 25494572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workforce development for comparative effectiveness research: training programs funded by the American Recovery and Reinvestment Act.
    Geonnotti KL; Rich EC; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):609-15. PubMed ID: 25494567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Recovery and Reinvestment Act-comparative effectiveness research infrastructure investments: emerging data resources, tools and publications.
    Segal C; Holve E
    J Comp Eff Res; 2014 Nov; 3(6):647-55. PubMed ID: 25494571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.
    Zickafoose JS; Kimmey LD; Tomas A; Esposito D; Rich E
    J Comp Eff Res; 2014 Nov; 3(6):667-75. PubMed ID: 25494573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building electronic data infrastructure for comparative effectiveness research: accomplishments, lessons learned and future steps.
    Randhawa GS
    J Comp Eff Res; 2014 Nov; 3(6):567-72. PubMed ID: 25494561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research: a progress report.
    Sox HC
    Ann Intern Med; 2010 Oct; 153(7):469-72. PubMed ID: 20679544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does US$1.1 billion buy? An investment in the future.
    Simpson LA
    J Comp Eff Res; 2014 Nov; 3(6):561-3. PubMed ID: 25494559
    [No Abstract]   [Full Text] [Related]  

  • 13. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 14. The Electronic Data Methods (EDM) forum for comparative effectiveness research (CER).
    Holve E; Segal C; Lopez MH; Rein A; Johnson BH
    Med Care; 2012 Jul; 50 Suppl():S7-10. PubMed ID: 22692262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building sustainable multi-functional prospective electronic clinical data systems.
    Randhawa GS; Slutsky JR
    Med Care; 2012 Jul; 50 Suppl():S3-6. PubMed ID: 22692255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrastructure to support learning health systems: are we there yet? Innovative solutions and lessons learned from American Recovery and Reinvestment Act CER investments.
    Holve E; Segal C
    J Comp Eff Res; 2014 Nov; 3(6):635-45. PubMed ID: 25494570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A push for comparative effectiveness: US initiatives aim to empower patients, physicians. Interview by Bridget M. Kuehn.
    Clancy CM
    JAMA; 2012 Apr; 307(15):1570-1. PubMed ID: 22511672
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effectiveness research priorities at federal agencies: the view from the Department of Veterans Affairs, National Institute on Aging, and Agency for Healthcare Research and Quality.
    O'Leary TJ; Slutsky JR; Bernard MA
    J Am Geriatr Soc; 2010 Jun; 58(6):1187-92. PubMed ID: 20936736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 20. Healthcare ROI. Medical research, comparative-effectiveness studies deserve investment.
    May D
    Mod Healthc; 2013 Feb; 43(8):23. PubMed ID: 23516786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.